PAUL LAURENCE E 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Mar 8, 2011
Insider Transaction Report
Form 4
PAUL LAURENCE E
Director
Transactions
- Award
Deferred Share Units
2011-03-05+1,613→ 51,542 total→ Common Stock, no par value (1,613 underlying)
Footnotes (1)
- [F1]Each Deferred Share Unit entitles its holder, upon ceasing to be a director, to receive an amount of cash having the same value as one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. at such time.